Topics

Latest "Pharmaceutical Executive Conferences website" News Stories

06:25 EDT 20th August 2019 | BioPortfolio

Here are the most relevant search results for "Pharmaceutical Executive Conferences website" found in our extensive news archives from over 250 global news sources.

More Information about Pharmaceutical Executive Conferences website on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pharmaceutical Executive Conferences website for you to read. Along with our medical data and news we also list Pharmaceutical Executive Conferences website Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharmaceutical Executive Conferences website Companies for you to search.

Showing "Pharmaceutical Executive Conferences website" News Articles 1–25 of 16,000+

Tuesday 20th August 2019

Synlogic Discontinues Development of SYNB1020 to Treat Hyperammonemia

– SYNB1020 well tolerated in Phase 1b/2a study, but did not lower blood ammonia in patients with cirrhosis – – Company will focus resources on advancement of SYNB1618, SYNB1891 and new early development programs – Synlogic, Inc., (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced that it is disc...


Elanco Announces Agreement to Acquire Bayer’s Animal Health Business

Deal strengthens and accelerates Elanco’s Innovation, Portfolio, and Productivity (IPP) strategy, creating second largest animal health leader by global revenue Continues mid-single digit revenue growth; accelerates achievement of adjusted EBITDA and gross margin goals; accretive to adjusted EPS in first full year post-close, high single to low double-digit accretion in second year post-clos...

FDA grants fast track status to Moderna’s Zika vaccine

At present, the mRNA-1893 vaccine is being assessed in a phase 1 study to prevent Zika virus infection in healthy adults. The mRNA-1893 included an mRNA sequence that The post FDA grants fast track status to Moderna’s Zika vaccine appeared first on Pharmaceutical Business review.


NanoValent Pharmaceuticals Announces Issuance of United States Patent for Application of Targeted Polymerized Nanoparticles in Cancer Treatment

NanoValent Pharmaceuticals, Inc., today announced the acceptance and formal publication of United States Patent No. 10,369,104 from the U.S. Patent and Trademark Office relating to its application of targeted polymerized nanoparticles in cancer. At the same time, the company has moved into cGMP manufacturing to prepare for IND toxicology and the filing of a new drug application with NV103, a CD99...

Angel-funded Siamab completes £166m exit with large commercial-stage biopharma

Under the terms of the agreement, Siamab will receive a multimillion-dollar initial payment and is eligible to receive additional payments when specific milestones are achieved. No additional terms The post Angel-funded Siamab completes £166m exit with large commercial-stage biopharma appeared first on Pharmaceutical Business review.

Sustainable Manufacturing Practices Needed to Combat Growing Antimicrobial Resistance

Joint Workshop conducted in Korea by Centrient Pharmaceuticals and Indian Institute of Technology - Delhi, on Sustainable Manufacturing of Pharmaceuticals Centrient Pharmaceuticals, a global leader in sustainable antibiotics manufacturing, in partnership with Indian Institute of Technology - Delhi, organized a workshop on ‘Sustainability Through Excellence in Manufacturing’ (STEM) in Seoul t...

Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Powder for Oral Solution, USP in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Vigabatrin Powder for Oral Solution, USP in 500 mg per packet, a therapeutic equivalent generic version of Sabril® (vigabatrin) Powder for Oral Solution, USP, approved by the U.S. Food and Drug Administration (USFDA). The ...

PredictImmune Appoints Tim Rea of BGF as Non-Executive Director

Experienced entrepreneur and investor appointed with immediate effect PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, is delighted to welcome Tim Rea, an investor at BGF, to its board. Tim has been active in the venture capital and start-up ecosystem for over 20 years across a broad range of sect...

Vaxxilon Awarded CARB-X Grant to Advance Novel Prophylactic Vaccine to Prevent Klebsiella pneumoniae Infections

Vaxxilon, a privately held company working on synthetic vaccines, has been awarded a grant of up to $1.4 million from CARB-X, with the possibility of $3.1 million more based on the achievement of milestones, to develop the first prophylactic vaccine for the prevention of carbapenem resistant Klebsiella pneumoniae (crKP). “The complete CARB-X award will enable us to conduct the full preclinica...

Monday 19th August 2019

Dogs Might Benefit from Regular Brushing but Humans Should Look After Their Own Teeth First, says Premier Care Dental Group

The Pasadena-based oral healthcare groups comments on a recent article saying that discussions around how often to brush a dog’s teeth mirror concerns around oral hygiene for homo sapiens. PASADENA, Calif. (PRWEB) August 19, 2019 A July 26 article on Reader’s Digest discusses how at least one expert suggests that dog owners should be brushing their pets’ teeth twice a day. The acknowledges ...

Health Dialog Services Corp Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

Health Dialog Services Corp Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your ...

Patterson Companies First-Quarter Fiscal 2020 Conference Call Scheduled for Thursday, August 29, 2019

Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2020 first-quarter conference call on Thursday, August 29, 2019 at 9 a.m. CT (10 a.m. ET). The company’s earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company’s website, www.PattersonCompanies.com. The first-quarter...

Ventas Announces Expiration and Results of Tender Offer for 4.25% Senior Notes Due 2022

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today the expiration and results of the previously announced offer by Ventas Realty, Limited Partnership (“Ventas Realty”) and Ventas Capital Corporation (“Ventas Capital” and, together with Ventas Realty, the “Issuers”), its wholly owned subsidiaries, to purchase for cash (the “Tender Offer”) any and all of th...

GoodRx Named to Fortune’s Change the World and Los Angeles Business Journal’s Best Places to Work Lists

Company Recognized for Positive Social Impact GoodRx, America’s leading resource for healthcare savings, today announced it has been named to the Fortune 2019 Change the World list and the Los Angeles Business Journal 2019 Best Places to Work list. GoodRx is ranked #27 on Fortune’s 2019 Change the World list. The award recognizes companies that have made an important social impact through ...

Mary Lynne Hedley Joins Veeva Board of Directors

Veeva adds 23-year life sciences industry veteran and executive leader Veeva Systems (NYSE:VEEV) today announced the appointment of Mary Lynne Hedley to the company’s Board of Directors. Dr. Hedley brings 23 years of experience leading numerous innovative life sciences companies. She is president and chief operating officer at TESARO, an oncology-focused pharmaceutical company she co-founded i...

Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock

Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced the closing of its previously announced registered underwritten public offering. 10,810,810 shares of the Company’s common stock at a price to the public of $37.00 per share were issued and sold in the offering. The gross procee...

Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its investigational Zika vaccine (mRNA-1893) currently being evaluated in a Phase 1 study for the p...

China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today announced that its Annual Report on From 20-F for the fiscal year ended March ...

Alive Appoints Kimberly Goessele as President and Chief Executive Officer

Healthcare Veteran Skilled in Business Development and Strategy Will Lead Expansion of Nonprofit Provider’s Hospice, Grief, and Education Services to Communities throughout Middle Tennessee Alive, one of the oldest hospices in the nation and the only nonprofit provider of hospice care and end-of-life services in Middle Tennessee, today announced the appointment of Kimberly Goessele as Preside...

Responding to Rising Demand, Botanacor Laboratories Expands Hemp Testing to All of North America

As the Only Lab Purpose-Built to Pass FDA Inspections and Audits, Botanacor Tests Hemp and Hemp-Derived CBD Products to Assure Product Quality and End-User Safety Botanacor Laboratories, the widely recognized leader in accredited testing of hemp biomass and hemp-derived CBD products, is responding to rising demand by offering industrial hemp and CBD testing not just in Colorado, but throughout a...

-Scientists use duoCAR-T therapy to fight #HIV -Executive shake-up at #Novartis after #Zolgensma data scandal -#Medicare will cover CAR-T therapies in United States -MS drug boosts effectiveness of #cancer therapy in treating #glioblastoma http://bit.ly/

-Scientists use duoCAR-T therapy to fight #HIV -Executive shake-up at #Novartis after #Zolgensma data scandal - #Medicare will cover CAR-T therapies in United States -MS drug boosts effectiveness of

Debbie McCune Davis to be honored with AZBio Public Service Award

The Arizona Bioindustry Association (AZBio) today announced that the Honorable Debbie McCune Davis, Executive Director of The Arizona Partnership for Immunization will receive the AZBio Public Service Award in recognition of her accomplishments during four decades of service to the community at the

BioMarin Pharmaceutical Inc BMRN Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

BioMarin Pharmaceutical Inc BMRN Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that a...

Novartis faces further fallout over Zolgensma

Filing shows executive sold almost $1m in shares 18 days before FDA launched data manipulation probe

Novartis executive sold $1m shares ahead of probe

Company faces possible civil or criminal charges over manipulated Zolgensma data


Quick Search

News Quicklinks